Grant Award Details

A Translating Center designed to expedite the development and delivery of high quality stem cell therapies to patients
Grant Type: 
Grant Number: 
INFR2-09298
Project Objective: 
  • A successful partnership, resulting in the creation of a Translating Center recognized as the leader in providing end-to-end preclinical development services (preclinical research, CMC, regulatory) to accelerate the availability of stem cell treatments to patients with unmet medical needs.

Investigator: 
Institution: 
Type: 
PI
Disease Focus: 
Multiple Indications (Alpha Clinics)
Award Value: 
$15,000,000
Status: 
Active

Progress Reports

Reporting Period: 
Operational Milestone #2

Grant Application Details

Application Title: 
  • A Translating Center designed to expedite the development and delivery of high quality stem cell therapies to patients
Public Abstract: 

A successful partnership, resulting in the creation of a Translating Center recognized as the leader in providing end-to-end preclinical development services (preclinical research, CMC, regulatory) to accelerate the availability of stem cell treatments to patients with unmet medical needs.

Statement of Benefit to California: 

The proposed Translating Center will benefit the lives of patients in CA with serious unmet medical needs by accelerating the development and delivery of high quality stem cell treatments and establishing CA’s position as a leader in advancing stem cell research. As the leading center of regenerative medicine, CA will attract patient advocates, drive science and academic innovation and reduce health care costs through curative treatments and stimulating economic growth.